Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure

JACC. Heart Failure
Yevgeniy KharitonJohn A Spertus

Abstract

This study sought to describe the health status of outpatients with heart failure and reduced ejection fraction (HFrEF) by sex, race/ethnicity, and socioeconomic status (SES). Although a primary goal in treating patients with HFrEF is to optimize health status, whether disparities by sex, race/ethnicity, and SES exist is unknown. In the CHAMP-HF (Change the Management of Patients with Heart Failure) registry, the associations among sex, race, and SES and health status, as measured by the Kansas City Cardiomyopathy Questionnaire-overall summary (KCCQ-os) score (range 0 to 100; higher scores indicate better health status) was compared among 3,494 patients from 140 U.S. clinics. SES was categorized by total household income. Hierarchical multivariate linear regression estimated differences in KCCQ-os score after adjusting for 31 patient characteristics and 10 medications. Overall mean KCCQ-os scores were 64.2 ± 24.0 but lower for women (29% of sample; 60.3 ± 24.0 vs. 65.9 ± 24.0, respectively; p < 0.001), for blacks (60.5 ± 25.0 vs. 64.9 ± 23.0, respectively; p < 0.001), for Hispanics (59.1 ± 21.0 vs. 64.9 ± 23.0, respectively; p < 0.001), and for those with the lowest income (<$25,000; mean: 57.1 vs. 63.1 to 74.7 for other income...Continue Reading

Citations

Jan 19, 2019·British Journal of Pharmacology·Ijeoma E ObiJennifer S Pollock
Jan 31, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Carlo Mario LombardiMarco Metra
May 1, 2020·Circulation·Connie White-WilliamsUNKNOWN American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epid
Jun 9, 2020·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Rachel G SinkeyAlan T Tita
Oct 17, 2019·ESC Heart Failure·Sarah J GutmanAndrew J Taylor
Oct 6, 2020·Circulation. Heart Failure·Nasrien E IbrahimUNKNOWN Prospective Study of Biomarkers, Symptom Improvement and Ventricular Remodeling During Entresto Therapy for Heart Failure (P
Nov 24, 2020·Current Treatment Options in Cardiovascular Medicine·Sujana BallaFatima Rodriguez
Mar 6, 2021·The American Journal of Cardiology·Shazli KhanSamir Saba
Feb 27, 2021·Frontiers in Cardiovascular Medicine·Piotr Z SobanskiSarah J Goodlin
Mar 25, 2021·Circulation. Cardiovascular Quality and Outcomes·Tiew-Hwa K TengUNKNOWN ASIAN-HF investigators‡
Mar 21, 2021·Current Opinion in Cardiology·Sabra C Lewsey, Khadijah Breathett
Jul 11, 2021·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Cancan ChenXiuzhen Fan
Aug 26, 2021·Journal of the American Heart Association·Sabra C Lewsey, Khadijah Breathett
Jul 3, 2021·Current Heart Failure Reports·Anubha AgarwalClare Arnott

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

SAS

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.